Bitcoin Options Review
At the beginning of last week, we began to pay much closer attention to bitcoin related plays as the digital currency was passing $28K and heading to new highs. We started by tracking the MARA 01/15 $13-15 Calls that morning, and added more targets to the mix this Monday morning in the form of the MARA Weekly $11-12 Calls and the RIOT Weekly $17-19 Calls. In the case of the latter two, they were our first fresh options ideas of the new trading year, so it’s nice to hit on those.
With Bitcoin surging to new all time highs once again, now trading between $34K and $35K we expect to have to come back yet again and report even further gains, but as of yesterday’s close, here were the excellent gains we had witnessed so far:
RIOT Weekly $17-19 Calls
$17: .65-2.24 (+245%)
$18: .52-1.67 (+221%)
$19: .35-1.19 (+240%)
MARA Weekly $11-12 Calls
$11: 1.32-3.90 (+195%)
$12: 1.06-3.25 (+207%)
MARA 01/15 $13-15 Calls
$13: .80-2.72 (+240%)
$14: .62-2.30 (+270%)
$15: .50-1.95 (+290%)
BLPG, LCLP, CBDL, TPII, USRM, VIBI
CURE Pharmaceutical Holding Corp. (OTCMKTS:CURR)
We’re looking back in on CURR this morning on the heels of a key PR released by the company that we would like to share with our readers. We have been following this stock for roughly a month, and this FDA IND approval news is by far the most exciting development yet.
CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for its product CUREfilm Blue™, an oral soluble film of sildenafil citrate (the active ingredient present in Viagra®1) for the treatment of erectile dysfunction (ED). CURE is seeking approval of this product via the 505(b)(2) regulatory pathway to expedite the U.S. approval process. (>>View Full PR via OTCMARKETS)
In addition to familiarizing yourself with the company’s news update, we would recommend you take a couple of minutes to check out the video presentation of the CURR chart that we have provided below:
Please direct any investor inquiries on CURR to:
Plum Tree Consulting LLC
Phone: (718) 224-3123
Cell: (516) 455-7662
Fresh Options Ideas:
SPY 01/06 $368-367 Puts
TSPG, WDLF, ISWH, USRM, OZSC, LBRMF
Yesterday morning, our primary order of business was to continue our commitment to bringing our readers as many solid quick-strike options ideas as we can. Not surprisingly, we were able to see some very nice opportunities in our designated targets.
Despite a mixed bag of bears and bulls, the volatile intraday swinging action of the markets made it possible to jump on big gains for each of them. Here were our top plays for the day and the total potential gains which could have been achieved.
SPY Weekly $244-242 Puts
$244: 1.30-2.89 (+122%)
$243: 1.08-2.49 (+131%)
$242.50: 1.04-2.37 (+128%)
$242: .97-2.19 (+126%)
KMX Weekly $50-55 Calls
$55: .50-3.90 (+680%)
$50: .30-2.03 (+577%)
Howard Hughes Corp. HHC – Fresh Options Idea
We want to place some options in the HHC chain on longer-term watch today after noticing some massive institutional insider buying that has come in near the stock’s recent lows, to the tune of $500M. You don’t sink those kind of funds into a stock unless you are supremely confident that its present level of support is rock solid. We are going to begin tracking the HHC 07/17 $50-60 Calls as a result.
BIEI, TPTW, MSTO, USRM, SPOM, AYTU